List of Excipients in API deferiprone
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing deferiprone
Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
---|---|---|---|---|---|
Chiesi USA Inc | FERRIPROX | deferiprone | 10122-100 | CELLULOSE, MICROCRYSTALLINE | |
Chiesi USA Inc | FERRIPROX | deferiprone | 10122-100 | HYPROMELLOSE 2910 | |
Chiesi USA Inc | FERRIPROX | deferiprone | 10122-100 | MAGNESIUM STEARATE | |
Chiesi USA Inc | FERRIPROX | deferiprone | 10122-100 | POLYETHYLENE GLYCOL 3350 | |
Chiesi USA Inc | FERRIPROX | deferiprone | 10122-100 | SILICON DIOXIDE | |
Chiesi USA Inc | FERRIPROX | deferiprone | 10122-100 | TITANIUM DIOXIDE | |
>Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing deferiprone
Detailed excipient profiles for deferiprone
Excipient focus: CELLULOSE, MICROCRYSTALLINE
deferiprone drug variants containing CELLULOSE, MICROCRYSTALLINE
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | deferiprone | 0054-0576 |
Chiesi USA Inc | deferiprone | 10122-100 |
Taro Pharmaceuticals USA Inc | deferiprone | 51672-4196 |
ApoPharma USA Inc | deferiprone | 52609-0006 |
>Company | >Ingredient | >NDC |
deferiprone drug variants not containing CELLULOSE, MICROCRYSTALLINE
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | deferiprone | 0054-0711 |
Chiesi USA Inc | deferiprone | 10122-101 |
Chiesi USA Inc | deferiprone | 10122-104 |
ApoPharma USA Inc | deferiprone | 52609-0007 |
ApoPharma USA Inc | deferiprone | 52609-4502 |
>Company | >Ingredient | >NDC |
Excipient focus: CROSPOVIDONE
deferiprone drug variants containing CROSPOVIDONE
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | deferiprone | 0054-0576 |
Hikma Pharmaceuticals USA Inc | deferiprone | 0054-0711 |
ApoPharma USA Inc | deferiprone | 52609-0007 |
>Company | >Ingredient | >NDC |
deferiprone drug variants not containing CROSPOVIDONE
Company | Ingredient | NDC |
---|---|---|
Chiesi USA Inc | deferiprone | 10122-100 |
Chiesi USA Inc | deferiprone | 10122-101 |
Chiesi USA Inc | deferiprone | 10122-104 |
Taro Pharmaceuticals USA Inc | deferiprone | 51672-4196 |
ApoPharma USA Inc | deferiprone | 52609-0006 |
ApoPharma USA Inc | deferiprone | 52609-4502 |
>Company | >Ingredient | >NDC |
Excipient focus: FD&C YELLOW NO. 6
deferiprone drug variants containing FD&C YELLOW NO. 6
Company | Ingredient | NDC |
---|---|---|
Chiesi USA Inc | deferiprone | 10122-101 |
ApoPharma USA Inc | deferiprone | 52609-4502 |
>Company | >Ingredient | >NDC |
deferiprone drug variants not containing FD&C YELLOW NO. 6
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | deferiprone | 0054-0576 |
Hikma Pharmaceuticals USA Inc | deferiprone | 0054-0711 |
Chiesi USA Inc | deferiprone | 10122-100 |
Chiesi USA Inc | deferiprone | 10122-104 |
Taro Pharmaceuticals USA Inc | deferiprone | 51672-4196 |
ApoPharma USA Inc | deferiprone | 52609-0006 |
>Company | >Ingredient | >NDC |
Excipient focus: GLYCERIN
deferiprone drug variants containing GLYCERIN
Company | Ingredient | NDC |
---|---|---|
Chiesi USA Inc | deferiprone | 10122-101 |
ApoPharma USA Inc | deferiprone | 52609-4502 |
>Company | >Ingredient | >NDC |
deferiprone drug variants not containing GLYCERIN
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | deferiprone | 0054-0576 |
Hikma Pharmaceuticals USA Inc | deferiprone | 0054-0711 |
Chiesi USA Inc | deferiprone | 10122-100 |
Chiesi USA Inc | deferiprone | 10122-104 |
Taro Pharmaceuticals USA Inc | deferiprone | 51672-4196 |
ApoPharma USA Inc | deferiprone | 52609-0006 |
>Company | >Ingredient | >NDC |
Excipient focus: HYDROCHLORIC ACID
deferiprone drug variants containing HYDROCHLORIC ACID
Company | Ingredient | NDC |
---|---|---|
Chiesi USA Inc | deferiprone | 10122-101 |
ApoPharma USA Inc | deferiprone | 52609-4502 |
>Company | >Ingredient | >NDC |
deferiprone drug variants not containing HYDROCHLORIC ACID
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | deferiprone | 0054-0576 |
Hikma Pharmaceuticals USA Inc | deferiprone | 0054-0711 |
Chiesi USA Inc | deferiprone | 10122-100 |
Chiesi USA Inc | deferiprone | 10122-104 |
Taro Pharmaceuticals USA Inc | deferiprone | 51672-4196 |
ApoPharma USA Inc | deferiprone | 52609-0006 |
>Company | >Ingredient | >NDC |
Excipient focus: HYDROXYETHYL CELLULOSE
deferiprone drug variants containing HYDROXYETHYL CELLULOSE
Company | Ingredient | NDC |
---|---|---|
Chiesi USA Inc | deferiprone | 10122-101 |
ApoPharma USA Inc | deferiprone | 52609-4502 |
>Company | >Ingredient | >NDC |
deferiprone drug variants not containing HYDROXYETHYL CELLULOSE
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | deferiprone | 0054-0576 |
Hikma Pharmaceuticals USA Inc | deferiprone | 0054-0711 |
Chiesi USA Inc | deferiprone | 10122-100 |
Chiesi USA Inc | deferiprone | 10122-104 |
Taro Pharmaceuticals USA Inc | deferiprone | 51672-4196 |
ApoPharma USA Inc | deferiprone | 52609-0006 |
>Company | >Ingredient | >NDC |
Excipient focus: HYDROXYPROPYL CELLULOSE
deferiprone drug variants containing HYDROXYPROPYL CELLULOSE
Company | Ingredient | NDC |
---|---|---|
ApoPharma USA Inc | deferiprone | 52609-0007 |
>Company | >Ingredient | >NDC |
deferiprone drug variants not containing HYDROXYPROPYL CELLULOSE
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | deferiprone | 0054-0576 |
Hikma Pharmaceuticals USA Inc | deferiprone | 0054-0711 |
Chiesi USA Inc | deferiprone | 10122-100 |
Chiesi USA Inc | deferiprone | 10122-101 |
Chiesi USA Inc | deferiprone | 10122-104 |
Taro Pharmaceuticals USA Inc | deferiprone | 51672-4196 |
>Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
deferiprone drug variants containing HYPROMELLOSE
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | deferiprone | 0054-0576 |
Hikma Pharmaceuticals USA Inc | deferiprone | 0054-0711 |
>Company | >Ingredient | >NDC |
deferiprone drug variants not containing HYPROMELLOSE
Company | Ingredient | NDC |
---|---|---|
Chiesi USA Inc | deferiprone | 10122-100 |
Chiesi USA Inc | deferiprone | 10122-101 |
Chiesi USA Inc | deferiprone | 10122-104 |
Taro Pharmaceuticals USA Inc | deferiprone | 51672-4196 |
ApoPharma USA Inc | deferiprone | 52609-0006 |
ApoPharma USA Inc | deferiprone | 52609-0007 |
>Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE 2910
deferiprone drug variants containing HYPROMELLOSE 2910
Company | Ingredient | NDC |
---|---|---|
Chiesi USA Inc | deferiprone | 10122-100 |
ApoPharma USA Inc | deferiprone | 52609-0006 |
ApoPharma USA Inc | deferiprone | 52609-0007 |
>Company | >Ingredient | >NDC |
deferiprone drug variants not containing HYPROMELLOSE 2910
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | deferiprone | 0054-0576 |
Hikma Pharmaceuticals USA Inc | deferiprone | 0054-0711 |
Chiesi USA Inc | deferiprone | 10122-101 |
Chiesi USA Inc | deferiprone | 10122-104 |
Taro Pharmaceuticals USA Inc | deferiprone | 51672-4196 |
ApoPharma USA Inc | deferiprone | 52609-4502 |
>Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE ACETATE SUCCINATE 06081224
deferiprone drug variants containing HYPROMELLOSE ACETATE SUCCINATE 06081224
Company | Ingredient | NDC |
---|---|---|
Chiesi USA Inc | deferiprone | 10122-104 |
>Company | >Ingredient | >NDC |
deferiprone drug variants not containing HYPROMELLOSE ACETATE SUCCINATE 06081224
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | deferiprone | 0054-0576 |
Hikma Pharmaceuticals USA Inc | deferiprone | 0054-0711 |
Chiesi USA Inc | deferiprone | 10122-100 |
Chiesi USA Inc | deferiprone | 10122-101 |
Taro Pharmaceuticals USA Inc | deferiprone | 51672-4196 |
ApoPharma USA Inc | deferiprone | 52609-0006 |
>Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM OXIDE
deferiprone drug variants containing MAGNESIUM OXIDE
Company | Ingredient | NDC |
---|---|---|
Chiesi USA Inc | deferiprone | 10122-104 |
>Company | >Ingredient | >NDC |
deferiprone drug variants not containing MAGNESIUM OXIDE
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | deferiprone | 0054-0576 |
Hikma Pharmaceuticals USA Inc | deferiprone | 0054-0711 |
Chiesi USA Inc | deferiprone | 10122-100 |
Chiesi USA Inc | deferiprone | 10122-101 |
Taro Pharmaceuticals USA Inc | deferiprone | 51672-4196 |
ApoPharma USA Inc | deferiprone | 52609-0006 |
>Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
deferiprone drug variants containing MAGNESIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | deferiprone | 0054-0576 |
Hikma Pharmaceuticals USA Inc | deferiprone | 0054-0711 |
Chiesi USA Inc | deferiprone | 10122-100 |
Chiesi USA Inc | deferiprone | 10122-104 |
Taro Pharmaceuticals USA Inc | deferiprone | 51672-4196 |
ApoPharma USA Inc | deferiprone | 52609-0006 |
>Company | >Ingredient | >NDC |
deferiprone drug variants not containing MAGNESIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
Chiesi USA Inc | deferiprone | 10122-101 |
ApoPharma USA Inc | deferiprone | 52609-4502 |
>Company | >Ingredient | >NDC |
Excipient focus: METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER
deferiprone drug variants containing METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER
Company | Ingredient | NDC |
---|---|---|
Chiesi USA Inc | deferiprone | 10122-104 |
>Company | >Ingredient | >NDC |
deferiprone drug variants not containing METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | deferiprone | 0054-0576 |
Hikma Pharmaceuticals USA Inc | deferiprone | 0054-0711 |
Chiesi USA Inc | deferiprone | 10122-100 |
Chiesi USA Inc | deferiprone | 10122-101 |
Taro Pharmaceuticals USA Inc | deferiprone | 51672-4196 |
ApoPharma USA Inc | deferiprone | 52609-0006 |
>Company | >Ingredient | >NDC |
Excipient focus: METHYLCELLULOSE
deferiprone drug variants containing METHYLCELLULOSE
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | deferiprone | 0054-0711 |
ApoPharma USA Inc | deferiprone | 52609-0007 |
>Company | >Ingredient | >NDC |
deferiprone drug variants not containing METHYLCELLULOSE
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | deferiprone | 0054-0576 |
Chiesi USA Inc | deferiprone | 10122-100 |
Chiesi USA Inc | deferiprone | 10122-101 |
Chiesi USA Inc | deferiprone | 10122-104 |
Taro Pharmaceuticals USA Inc | deferiprone | 51672-4196 |
ApoPharma USA Inc | deferiprone | 52609-0006 |
>Company | >Ingredient | >NDC |
Excipient focus: PEPPERMINT OIL
deferiprone drug variants containing PEPPERMINT OIL
Company | Ingredient | NDC |
---|---|---|
Chiesi USA Inc | deferiprone | 10122-101 |
ApoPharma USA Inc | deferiprone | 52609-4502 |
>Company | >Ingredient | >NDC |
deferiprone drug variants not containing PEPPERMINT OIL
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | deferiprone | 0054-0576 |
Hikma Pharmaceuticals USA Inc | deferiprone | 0054-0711 |
Chiesi USA Inc | deferiprone | 10122-100 |
Chiesi USA Inc | deferiprone | 10122-104 |
Taro Pharmaceuticals USA Inc | deferiprone | 51672-4196 |
ApoPharma USA Inc | deferiprone | 52609-0006 |
>Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 1000
deferiprone drug variants containing POLYETHYLENE GLYCOL 1000
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | deferiprone | 0054-0576 |
Hikma Pharmaceuticals USA Inc | deferiprone | 0054-0711 |
>Company | >Ingredient | >NDC |
deferiprone drug variants not containing POLYETHYLENE GLYCOL 1000
Company | Ingredient | NDC |
---|---|---|
Chiesi USA Inc | deferiprone | 10122-100 |
Chiesi USA Inc | deferiprone | 10122-101 |
Chiesi USA Inc | deferiprone | 10122-104 |
Taro Pharmaceuticals USA Inc | deferiprone | 51672-4196 |
ApoPharma USA Inc | deferiprone | 52609-0006 |
ApoPharma USA Inc | deferiprone | 52609-0007 |
>Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 3350
deferiprone drug variants containing POLYETHYLENE GLYCOL 3350
Company | Ingredient | NDC |
---|---|---|
Chiesi USA Inc | deferiprone | 10122-100 |
ApoPharma USA Inc | deferiprone | 52609-0006 |
>Company | >Ingredient | >NDC |
deferiprone drug variants not containing POLYETHYLENE GLYCOL 3350
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | deferiprone | 0054-0576 |
Hikma Pharmaceuticals USA Inc | deferiprone | 0054-0711 |
Chiesi USA Inc | deferiprone | 10122-101 |
Chiesi USA Inc | deferiprone | 10122-104 |
Taro Pharmaceuticals USA Inc | deferiprone | 51672-4196 |
ApoPharma USA Inc | deferiprone | 52609-0007 |
>Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 8000
deferiprone drug variants containing POLYETHYLENE GLYCOL 8000
Company | Ingredient | NDC |
---|---|---|
ApoPharma USA Inc | deferiprone | 52609-0007 |
>Company | >Ingredient | >NDC |
deferiprone drug variants not containing POLYETHYLENE GLYCOL 8000
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | deferiprone | 0054-0576 |
Hikma Pharmaceuticals USA Inc | deferiprone | 0054-0711 |
Chiesi USA Inc | deferiprone | 10122-100 |
Chiesi USA Inc | deferiprone | 10122-101 |
Chiesi USA Inc | deferiprone | 10122-104 |
Taro Pharmaceuticals USA Inc | deferiprone | 51672-4196 |
>Company | >Ingredient | >NDC |
Excipient focus: POLYSORBATE 80
deferiprone drug variants containing POLYSORBATE 80
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | deferiprone | 0054-0576 |
Hikma Pharmaceuticals USA Inc | deferiprone | 0054-0711 |
>Company | >Ingredient | >NDC |
deferiprone drug variants not containing POLYSORBATE 80
Company | Ingredient | NDC |
---|---|---|
Chiesi USA Inc | deferiprone | 10122-100 |
Chiesi USA Inc | deferiprone | 10122-101 |
Chiesi USA Inc | deferiprone | 10122-104 |
Taro Pharmaceuticals USA Inc | deferiprone | 51672-4196 |
ApoPharma USA Inc | deferiprone | 52609-0006 |
ApoPharma USA Inc | deferiprone | 52609-0007 |
>Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
deferiprone drug variants containing SILICON DIOXIDE
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | deferiprone | 0054-0576 |
Chiesi USA Inc | deferiprone | 10122-100 |
Chiesi USA Inc | deferiprone | 10122-104 |
Taro Pharmaceuticals USA Inc | deferiprone | 51672-4196 |
ApoPharma USA Inc | deferiprone | 52609-0006 |
>Company | >Ingredient | >NDC |
deferiprone drug variants not containing SILICON DIOXIDE
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | deferiprone | 0054-0711 |
Chiesi USA Inc | deferiprone | 10122-101 |
ApoPharma USA Inc | deferiprone | 52609-0007 |
ApoPharma USA Inc | deferiprone | 52609-4502 |
>Company | >Ingredient | >NDC |
Excipient focus: SUCRALOSE
deferiprone drug variants containing SUCRALOSE
Company | Ingredient | NDC |
---|---|---|
Chiesi USA Inc | deferiprone | 10122-101 |
ApoPharma USA Inc | deferiprone | 52609-4502 |
>Company | >Ingredient | >NDC |
deferiprone drug variants not containing SUCRALOSE
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | deferiprone | 0054-0576 |
Hikma Pharmaceuticals USA Inc | deferiprone | 0054-0711 |
Chiesi USA Inc | deferiprone | 10122-100 |
Chiesi USA Inc | deferiprone | 10122-104 |
Taro Pharmaceuticals USA Inc | deferiprone | 51672-4196 |
ApoPharma USA Inc | deferiprone | 52609-0006 |
>Company | >Ingredient | >NDC |
Excipient focus: TALC
deferiprone drug variants containing TALC
Company | Ingredient | NDC |
---|---|---|
Chiesi USA Inc | deferiprone | 10122-104 |
>Company | >Ingredient | >NDC |
deferiprone drug variants not containing TALC
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | deferiprone | 0054-0576 |
Hikma Pharmaceuticals USA Inc | deferiprone | 0054-0711 |
Chiesi USA Inc | deferiprone | 10122-100 |
Chiesi USA Inc | deferiprone | 10122-101 |
Taro Pharmaceuticals USA Inc | deferiprone | 51672-4196 |
ApoPharma USA Inc | deferiprone | 52609-0006 |
>Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
deferiprone drug variants containing TITANIUM DIOXIDE
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | deferiprone | 0054-0576 |
Hikma Pharmaceuticals USA Inc | deferiprone | 0054-0711 |
Chiesi USA Inc | deferiprone | 10122-100 |
Chiesi USA Inc | deferiprone | 10122-104 |
ApoPharma USA Inc | deferiprone | 52609-0006 |
ApoPharma USA Inc | deferiprone | 52609-0007 |
>Company | >Ingredient | >NDC |
deferiprone drug variants not containing TITANIUM DIOXIDE
Company | Ingredient | NDC |
---|---|---|
Chiesi USA Inc | deferiprone | 10122-101 |
Taro Pharmaceuticals USA Inc | deferiprone | 51672-4196 |
ApoPharma USA Inc | deferiprone | 52609-4502 |
>Company | >Ingredient | >NDC |
Excipient focus: TRIETHYL CITRATE
deferiprone drug variants containing TRIETHYL CITRATE
Company | Ingredient | NDC |
---|---|---|
Chiesi USA Inc | deferiprone | 10122-104 |
>Company | >Ingredient | >NDC |
deferiprone drug variants not containing TRIETHYL CITRATE
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | deferiprone | 0054-0576 |
Hikma Pharmaceuticals USA Inc | deferiprone | 0054-0711 |
Chiesi USA Inc | deferiprone | 10122-100 |
Chiesi USA Inc | deferiprone | 10122-101 |
Taro Pharmaceuticals USA Inc | deferiprone | 51672-4196 |
ApoPharma USA Inc | deferiprone | 52609-0006 |
>Company | >Ingredient | >NDC |
Excipient focus: WATER
deferiprone drug variants containing WATER
Company | Ingredient | NDC |
---|---|---|
Chiesi USA Inc | deferiprone | 10122-101 |
ApoPharma USA Inc | deferiprone | 52609-4502 |
>Company | >Ingredient | >NDC |
deferiprone drug variants not containing WATER
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | deferiprone | 0054-0576 |
Hikma Pharmaceuticals USA Inc | deferiprone | 0054-0711 |
Chiesi USA Inc | deferiprone | 10122-100 |
Chiesi USA Inc | deferiprone | 10122-104 |
Taro Pharmaceuticals USA Inc | deferiprone | 51672-4196 |
ApoPharma USA Inc | deferiprone | 52609-0006 |
>Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.